Infant

21 drugs in development·14 companies·1 clinical trial

Drug Pipeline by Phase

Approved(11)

Drug	Company
diphenhydramine	ACHIEVE LIFE SCIENCES, INC. (ACHV)
diphenhydramine	Miromatrix Medical Inc. (MIRO)
Nabi-HB	ADMA BIOLOGICS, INC. (ADMA)
neoprofen	Ultragenyx Pharmaceutical Inc. (RARE)
Poly-Vi-Flor	AYTU BIOPHARMA, INC (AYTU)
Pombiliti + Opfolda	AMICUS THERAPEUTICS, INC. (FOLD)
Pombiliti™ + Opfolda™	AMICUS THERAPEUTICS, INC. (FOLD)
Similac® (and related Similac formulas listed)	ABBOTT LABORATORIES (ABT)
Similac® family	ABBOTT LABORATORIES (ABT)
Tri-Vi-Flor	AYTU BIOPHARMA, INC (AYTU)
vigabatrin	DR REDDYS LABORATORIES LTD (RDY)

Phase 3(4)

Drug	Company
ANAVEX®2-73	ANAVEX LIFE SCIENCES CORP. (AVXL)
Cipaglucosidase Alfa	AMICUS THERAPEUTICS, INC. (FOLD)
Miglustat	AMICUS THERAPEUTICS, INC. (FOLD)
probiotic	GH Research PLC (GHRS)

Phase 2(2)

Drug	Company
mas825	Novartis AG (NVS)
MAS825	Novartis AG (NVS)

Preclinical(1)

Drug	Company
vby329	Invivyd, Inc. (IVVD)

Unknown(3)

Drug	Company
cerliponase alfa	BIOMARIN PHARMACEUTICAL INC (BMRN)
CLN1 program (out-licensed to Taysha)	ABEONA THERAPEUTICS INC. (ABEO)
Similac® (and variants)	ABBOTT LABORATORIES (ABT)

BioSniper tracks 21 drugs in development for Infant across 14 companies.

There are 1 clinical trial targeting Infant tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.